Background & Purpose
Sleep apnea has emerged as a potent risk factor for stroke recurrence and mortality. The burden of sleep apnea among stroke survivors in sub-Saharan Africa where stroke incidence and mortality are escalating is unknown. We sought to assess the prevalence of sleep apnea risk and its clinical correlates and predictors among Ghanaian stroke survivors.
Methods
This cross-sectional study involved 200 consecutive stroke survivors attending a Neurology clinic in a tertiary medical center in Kumasi, Ghana. The validated Berlin, STOP-BANG and Epworth Sleepiness Scale questionnaires were administered to all eligible subjects to assess sleep apnea risk and daytime somnolence after collecting demographic, clinical, health-related quality of life, and symptoms of depression using questionnaires.
Results
Median (IQR) age of stroke survivors was 62 (52–72) years and 52.5% were males. 99 (49.5%) subjects were identified as high risk for sleep apnea using the Berlin questionnaire while the STOP-BANG questionnaire classified 26 (13%), 137 (68.5%) and 37 (18.5%) subjects as low, intermediate and high risk for SA respectively. Patients at high risk of sleep apnea were significantly older, used excess alcohol and were less able to perform activities of daily living, although their mean NIHSS scores were significantly lower than those with low risk for sleep apnea. None of the stroke survivors had ever been screened for SA.
Conclusions
One out of every two stroke survivors attending a Neurology clinic in Ghana is at high risk for undiagnosed sleep apnea. Greater regional awareness about sleep apnea presence and outcomes among patients and providers is warranted.